Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Cafergot (ergotamine tartrate and caffeine) suppositories, Novartis Corp NDA 9-000/S-022/S-023 CAFFEINE; ERGOTAMINE TARTRATE Suppository; Rectal 100MG;2MG CAFERGOT NOVARTIS 084294 CAFFEINE; ERGOTAMINE TARTRATE Tablet; 100MG;1MG ERCATAB Geneva 040453 DIHYDROERGOTAMINE MESYLATE Injection 1MG/ML DIHYDROERGOTAMINE MESYLATE Bedford 040475 DIHYDROERGOTAMINE MESYLATE Injection 1MG/ML DIHYDROERGOTTAMINE MESYLATE Paddock 005929 DIHYDROERGOTAMINE MESYLATE Injection 1MG/ML D.H.E. 45 XCEL 020148 DIHYDROERGOTAMINE MESYLATE Spray, Metered; Nasal 0.5MG/INH MIGRANAL XCEL 087693 ERGOTAMINE TARTRATE Tablet; Sublingual 2MG ERGOMAR HARVEST | Ergotamine Tartrate and caffeine, West-Ward Pharma, Approval | Ergotamine Tartrate/ Caffeine Tablets, Mikart., Approval ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com